Loading…
A need for tailored approach for patients with symptomatic intracranial atherosclerotic stenosis
Patients from the US were older, one-third had a prior stroke, one-fifth had coronary artery disease, 44% were on anti-platelet medication and 47% were on statin medication prior to admission. Patients with ICAS have a diverse spectrum of vascular phenotype, with variable degree of stenosis (presenc...
Saved in:
Published in: | Annals of the Indian Academy of Neurology 2020-05, Vol.23 (3), p.253-254 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Patients from the US were older, one-third had a prior stroke, one-fifth had coronary artery disease, 44% were on anti-platelet medication and 47% were on statin medication prior to admission. Patients with ICAS have a diverse spectrum of vascular phenotype, with variable degree of stenosis (presence of sub-clinical perfusion deficits), focal and diffuse atherosclerosis pattern, collateral artery distribution and plaque enhancement suggestive of inflammation, hemorrhage and vascularity. [7] RIC has been tested in a phase 2 study in patients with ICAS and shown to reduce the annual incidence of recurrent stroke and improvement in cerebral blood flow. |
---|---|
ISSN: | 0972-2327 1998-3549 |
DOI: | 10.4103/aian.AIAN_623_19 |